Here's a look at some of the top regulatory stories for medical device companies this week: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device; Medtronic launches Verify incontinence device in the U.S.; FDA OKs Integra Lifesciences Puerto Rico plant; FDA approves Bard's Lutonix DEB
UPDATE: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device
October 9, 2014 by Brad Perriello
Boston Scientific, C.R. Bard, Food & Drug Administration (FDA), Integra LifeSciences Corp., Medtronic
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1sctSab
Cap comentari:
Publica un comentari a l'entrada